Commentary about open-label randomized controlled study of ivermectin in mild to moderate COVID-19. IMC Journal of Medical Science, [S. l.], v. 14, n. 2, p. 67–68, 2021. DOI: 10.3329/imcjms.v14i2.52833. Disponível em: https://banglajol.info/index.php/IMCJMS/article/view/52833. Acesso em: 23 jun. 2026.